01 5Atozet
02 15Lipitor
Main Therapeutic Indication : Cardiovascular Diseases
Currency : USD
2020 Revenue in Millions : 100
2019 Revenue in Millions : 121
Growth (%) : -17
Main Therapeutic Indication : Cardiovascular Diseases
Currency : USD
2019 Revenue in Millions : 1,973
2018 Revenue in Millions : 2,062
Growth (%) : -4
Main Therapeutic Indication : Cardiovascular Diseases
Currency : USD
2020 Revenue in Millions : 453
2019 Revenue in Millions : 391
Growth (%) : 16
Main Therapeutic Indication : Cardiovascular Diseases
Currency : USD
2021 Revenue in Millions : 19
2020 Revenue in Millions : 99
Growth (%) : -80
Main Therapeutic Indication : Cardiovascular Diseases
Currency : USD
2021 Revenue in Millions : 458
2020 Revenue in Millions : 453
Growth (%) : 1
Main Therapeutic Indication : Cardiology/Vascular Diseases
Currency : USD
2022 Revenue in Millions : 457
2021 Revenue in Millions : 458
Growth (%) : 0
Main Therapeutic Indication : Cardiology/Vascular Diseases
Currency : USD
2022 Revenue in Millions : 1,635
2021 Revenue in Millions : 1,663
Growth (%) : -2
Main Therapeutic Indication : Cardiology/Vascular Diseases
Currency : USD
2023 Revenue in Millions : 1,559
2022 Revenue in Millions : 1,635
Growth (%) : -5
Main Therapeutic Indication : Cardiology/Vascular Diseases
Currency : USD
2023 Revenue in Millions : 519
2022 Revenue in Millions : 457
Growth (%) : 14
Main Therapeutic Indication : Cardiovascular Diseases
Currency : USD
2018 Revenue in Millions : 144
2017 Revenue in Millions : 185
Growth (%) : -22%
LOOKING FOR A SUPPLIER?